The modern, dynamically developing Russian pharmaceutical company, one of the leaders in the pharmaceutical industry of the Russian Federation in terms of growth rates.
Skopinpharm is a developer and manufacturer of medicines, one of the leading suppliers under the program of 14 high-cost nosologies in accordance with the Ministry of Health of the Russian Federation orders. Skopinpharm offers a range of medications under the regional preferential insurance program, and is also one of the main suppliers of the Circle of Good Foundation for helping children with serious and life-threatening illnesses. The company's turnover amounted to more than 44.1 billion rubles by 2024.
The company operates in the following key areas: manufacture of plasma-derived medicinal products, cytostatics, and medicinal products used for the treatment of various oncological diseases. As part of developing these business areas, the company has constructed new manufacturing and storage buildings, performs technology transfer of unique pharmaceutical manufacturing processes, and has built a plasma storage facility with a laboratory unit, which will ensure proper storage of plasma intended for fractionation (raw materials for the manufacture of human plasma-derived medicinal products).
At the same time, in partnership with health authorities, a modern system for the procurement of blood plasma is being created and a voluntary donation program is being developed.
Skopinpharm actively supports the training and advanced training of pharmaceutical industry specialists and is one of the founders of the Academy of Good Practices of the EAEU.
Skopinpharm LLC
The address: Building 1, Industrial Zone No. 1, Skopin District, Ryazan Region, Russia, 391800.
info@skopinpharm.com
Swixx BioPharma was founded to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE and beyond, that the multinational biopharma chooses not to enter, or to exit. With its expansion, Swixx BioPharma evolved into a professional and reliable partner with the highest standards in the areas where we operate.
At Swixx, we believe that everyone deserves access to the best medical solutions to live healthier and better lives. Although we are a pharmaceutical company without our own portfolio and research and development (R&D), we are committed to pursuing the standards and culture of a multinational pharmaceutical company.
We are highly experienced professionals, and our background is our strength. We joined forces and use our knowledge to constantly live up to our mission of providing access to the modern medicines of our partners.
Alisa has over 20 years of experience in the pharmaceutical industry.
She worked at Roche for about 10 years in Marketing Department.
In 2012, Alisa joined Bristol-Myers Squibb as Project Manager for Immunology and Oncology in Market Access Department.
In 2014, she moved to the position of Regional Market Access Managers Head.
From 2017 to 2021, she held the position of Market Access and Pricing Department Director, during which time Alisa also had experience as Commercial Director and Acting General Director.
Since December 2021, she has been transferred to the position of Oncology Department Director.
In June 2022, Alisa joined Swixx Healthcare, as a Director of Oncology and Market Access Departments. Since January 2023, she has held the position of Deputy General Director.
Alisa graduated from the 1st Moscow State Medical University I.M. Sechenov, received a PhD in Pharmaceutical Sciences.
Date of birth: 28 January 1957
Place of birth: Lviv, Ukrainian SSR
Education:
1974 – 1979 Lviv State Medical Institute (speciality - pharmacist).
1982 – 1986 Lviv State University, Faculty of Economics (speciality - economist).
Professional experience:
2009 – Present Pharmeco LLC Chairman of the Board
He has many years of experience in the Pharmaceutical industry, production management and international business.
From 15.03.2015 to the present — Chairman of the Board of Trustees of the Charitable Foundation named after the Holy Prince Vladimir.
Awards and Recognitions:
Reference information:
V.E. Babiy is the founder and shareholder of Pharmeco Group.
Pharmeco LLC is the managing company of the Group's production facilities and drug development and registration centers.